C. Michael White

Pharm.D., FCP, FCCP, FASHP

Department of Pharmacy Practice

---

Educational Background

• Fellowship, UConn School of Pharmacy/Hartford Hospital, 1998
• Pharm.D., Albany College of Pharmacy, Albany, NY, 1996
• B.S., Pharmacy, Albany College of Pharmacy, Albany, NY, 1994

Responsibilities

Administration, Teaching, Scholarship, and Public Engagement

Teaching Expertise

Dr. White’s teaching focuses on clinical pharmacology, nutrition and self-care, ethics and leadership, and the sustainability of the healthcare system. He has been selected “Teacher of the Year” four times and received the University’s higher teaching award, the UConn Center for Excellence in Teaching and Learning (CETL) Teaching Fellow.

Research Interests

Dr. White’s research interests are in the areas of comparative effectiveness and preventing adverse events from drugs, dietary supplements, substances of abuse, quasi-legal products, and medical devices. His over 500 peer reviewed publications and book chapters have resulted in 19,656 citations, H-index of 72, and i10 index of 276; placing him within the top 2% of researchers worldwide according to Elsevier. His work has been published in JAMA, Lancet, Annals of Internal Medicine, Circulation, Clinical Toxicology, and many others. Research awards include the ACCP Young Investigator of the Year, AACP Lyman Award, six-time recipient of the ASHP Foundation Drug Therapy Research Award and the ASHP Award for Sustained Contributions to the Literature (a lifetime achievement award for scholarly excellence).

His main research successes were establishing the nationally adopted AFIST regimen for preventing post-cardiothoracic surgery atrial fibrillation and stroke, establishing the role of magnesium to reduce the risk of drug induced Torsade de Pointes, discovering that ephedra multi-component products concerningly raised the blood pressure and QTc intervals of consumers (supporting the FDA’s ephedra ban from the US market), evaluating the use of psychedelics for mental health disorders, enhancing understanding of lipid lowering strategies and statin induced muscle issues, disseminating issues with FDA oversight of products (generic medications, dietary supplements, counterfeit medications) and clinical trials, legal loopholes for GLP-1s and substances of abuse that bypass normal regulatory processes and jeopardizes human health, and establishing the benefits and risks of kratom and its alkaloids.

Public Engagement

Dr. White has appeared on major TV (NBC News, Good Morning America, PBS NewsHour, BBC, CNN, The National Desk, The Dr Oz Show), radio (WNPR, Sirius XM (Doctor Radio, BYU Radio)), newspapers (NY Times, USA Today, Washington Post, LA Times, Boston Globe), and magazines (Newsweek, Prevention, National Geographic, Discover) as well as hundreds of other (inter)national media outlets with a media reach exceeding 2.5 billion. His media commentaries in The Conversation has over 1.95 million readers. He had a recurring segment on NBC30 and then FOX61 in CT from 2007 to 2021 where he shared medical news with the public.

He has worked on migrant farmworker health clinics and in homeless shelters. During COVID-19 he helped spearhead the training of hundreds of new vaccinators across Connecticut in collaboration with the Department of Public Health and personally supported immunization clinics in underserved cities and rural towns as part of the FEMA mobile unit. He has coordinated multiple events to combat the opioid epidemic including UConn events to train vulnerable populations on how to use naloxone, rescue breathing, and fentanyl/xylazine test strips, and chairs the national Kratom Consumer Advisory Council. He has presented his research before the FDA NDAC advisory committee, the Medicaid Clinical Advisory Council (MedCAC), Agency for Healthcare Research and Quality, FDA/Duke Margolis Center Panel on Drug Quality, and National Association of State Controlled Substance Agents in addition to presenting abstracts at the American Heart Association, European Society of Emergency Medicine, and nearly all major American Pharmacy Organizations.

For his work with the media and in the community, he received the Provost’s Award for Public Engagement (Faculty Category) in 2014 and for his teams’ work on combatting COVID-19 misinformation through the creation of YouTube Videos on vaccinations in 5 languages, they won in 2021 (Student-Faculty Team) as well. He was on a team that won the AACP Weaver Award for Public Engagement in 2021 and the Hartford Business Journal COVID Healthcare Hero’s Award in 2021. He is a longstanding member of the national ASHP Research Advisory Committee and served as its vice-chair and then chair.

You can follow Dr. White on Twitter @CMichaelWhite2. He is on the editorial boards of the Annals of Pharmacotherapy and Pharmacy Practice News.

Clinical Interests

Improving clinical outcomes for patients by reducing drug (prescription, OTC, illicit), supplement, procedure, and device induced disease.

Professional Affiliations

Fellow of the American Society of Health System Pharmacists, Fellow of American College of Clinical Pharmacy, and fellow of the American College of Clinical Pharmacologists. He is a member of the American Association of Colleges of Pharmacy and Connecticut Pharmacists Association.

Selected Publications

Publications on PubMed

ResearchGate Profile

Google Scholar Profile